Back to top
more

INC Research Holdings, Inc. (SYNH)

(Delayed Data from NSDQ)

$47.27 USD

47.27
483,054

+0.56 (1.20%)

Updated May 3, 2019 04:00 PM ET

After-Market: $47.36 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance

by Zacks Equity Research

We are optimistic about Abbott's (ABT) strong and consistent EPD and Medical Devices performance organically.

QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits

by Zacks Equity Research

The launch of the kits is expected to bolster QIAGEN's (QGEN) Life Sciences Business Area

Urmimala Biswas headshot

Thermo Fisher Gets a Boost from Buyouts and Global Expansion

by Urmimala Biswas

Thermo Fisher (TMO) registers a solid international performance with strong growth in Europe and Asia-Pacific including China.

QIAGEN Down on Dim Q3 Prelim Sales, Startling CEO Departure

by Zacks Equity Research

If the dismal preliminary sales performance was not enough, then the news pertaining to QIAGEN's (QGEN) current CEO Peer M. Schatz's stepping down came as another huge blow.

Smith & Nephew's (SNN) STITCH Study Outcome Encouraging

by Zacks Equity Research

This can be considered a major step in Smith & Nephew's (SNN) commitment toward strengthening its Global Sports Medicine and ENT segment.

Medtronic Gets FDA's Breakthrough Device Nod for Valiant TAAA

by Zacks Equity Research

This FDA designation is expected to bolster Medtronic's (MDT) Aortic, Peripheral & Venous line within the broader Cardiac and Vascular group.

SYNH vs. NXGN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

SYNH vs. NXGN: Which Stock Is the Better Value Option?

Syneos Health (SYNH) Up 1.2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks.com featured highlights include: Syneos, Carlisle, United Technologies, Ares Capital and Principal Financial

by Zacks Equity Research

Zacks.com featured highlights include: Syneos, Carlisle, United Technologies, Ares Capital and Principal Financial

Swayta Shah headshot

Add These 5 Stocks With Solid Sales Growth to Your Portfolio

by Swayta Shah

Robust sales growth is the key to survival in today's fast changing and highly competitive operating backdrop.

SYNH or CERN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SYNH vs. CERN: Which Stock Is the Better Value Option?

Are Investors Undervaluing Syneos Health (SYNH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

3 Reasons Growth Investors Will Love Syneos Health (SYNH)

by Zacks Equity Research

Syneos Health (SYNH) could produce exceptional returns because of its solid growth attributes.

HMS Holdings (HMSY) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

HMS Holdings (HMSY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's Why You Should Invest in Cooper Companies Stock Now

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.

Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now

by Zacks Equity Research

HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services as well as robust margins.

SYNH or HMSY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

SYNH vs. HMSY: Which Stock Is the Better Value Option?

Syneos Health (SYNH) Q2 Earnings Beat Estimates, '19 View Up

by Zacks Equity Research

We are upbeat about Syneos Health's (SYNH) strong year-over-year revenue growth across both operating segments.

Syneos Health (SYNH) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Syneos Health (SYNH) delivered earnings and revenue surprises of 5.71% and 1.60%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Syneos Health (SYNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Syneos Health (SYNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SYNH vs. HMSY: Which Stock Is the Better Value Option?

by Zacks Equity Research

SYNH vs. HMSY: Which Stock Is the Better Value Option?

Why Is Syneos Health (SYNH) Up 4.6% Since Last Earnings Report?

by Zacks Equity Research

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Syneos' (SYNH) Q1 Earnings Miss Estimates, Revenues In Line

by Zacks Equity Research

Syneos Health (SYNH) sees strong year-over-year revenue growth across both operating segments ??? Clinical Solutions and Commercial Solutions.

Syneos Health (SYNH) Misses Q1 Earnings Estimates

by Zacks Equity Research

Syneos Health (SYNH) delivered earnings and revenue surprises of -1.67% and 0.02%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Syneos Health (SYNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.